News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...


Recent Postings


Archive


Tags

Editas (EDIT) OncoCyte (OCX) Tysabri IDERA (IDRA) BIOMARIN (BMRN) KITE (KITE) Illumina (ILMN) RenenxBio (RGNX) Mirati Therapeutics (MRTX) Alnylam (ALNY) AERIE PHARMACEUTICALS Herceptin Vitae Pharmaceuticals (VTAE) Multiple Myeloma JUNO (JUNO) Spike Therapeutics (ONCE) JOUNCE THERAPEUTICS (JNCE) Roche (ROCHE) AGOS (ARGS) Agenus (AGEN) ISIS (ISIS) LEXICON (LXRX) Seattle Genetics (SGEN) AstraZeneca (AZN) Advaxis (ADXS) GlaxoSmithKline (GSK) TOKAI (TKAOI) NOVOCURE (NVCR) REGULUS (RGLS) Anacor (ANAC) Bristol-Myers Squibb (BMY) Roche (RHHBY) PTC Therapeutics (PTCT) Valeant Pharmaceuticals International (VRX) CompuGen (CGEN) Anadys (ANDS) Inovio (INO) Benlysta (belimumab) ADVENTRIX (ANX) Ariad (ARIA) Micromet (MITI) Array Pharmaceuticals (ARRY) Telaprevir Sequenom (SQNM) Ocular Therapeutix (OCUL) ImmunoGen (IMGN) GUARDIAN HEALTH ABBVIE (ABBV) Gilead (GILD) Elan (ELN) Prolor Biotech (PBTH) SERES THERAPEUTICS (MCRB) Agenus (AGEN Exelixis (EXEL) MODERNA Alder Biopharmaceuticals (ALDR) Rapamune Zerenex NEKTAR (NKTR)) Theravance Bio Pharma (TBPH) Global Cell Therapeutics (GBT) Amgen (AMGN) Human Genome Sciences (HGSI) Intrexon (XON) Regeneron (REGN) Merck (MRK) Idenix (IDIX) Sangamo (SGMO) VANDA (VNDA) Intermune (ITMN) CRISPR Therapeutics (CRSP) Pluristem (PSTI) Abbott Laboratories (ABT) NEUROCRINE (NBIX) Aimmune Therapeutics (AIMT) Galena (GALE) Dynavax (DVAX) Velcade (bortezomib) Genentech Adaptimmune (ADAP) Xoma (XOMA) Onyx (ONXX) Sanofi (SNY) PORTOLA (PTLA) Ionis (IONS) INNOVIVA (INVA) Jazz Pharmaceuticals (JAZZ) Cytokinetics (CYTK) Trastuzumab-DM1 ARCA (ABIO) Revlimid (lenolidamide) ZALTRAP™ Bellicum (BLCM) Ziofpharm (ZIOP) Sanofi (SNA) HALOZYME (HALO) NANTKWEST (NK) galapagos (GLPG) Intercept (ICPT) CEMPRA (CEMP) SUNESIS PHARMACEUTICALS (SNSS) Incyte (INCY) Biocryst (BCRX) Vertex (VRTX) Sanofi-Aventis (SAN) Theravance (THRX) Ridaforolimus KERYX (KERX) Human Longevity (HLI) Endometrial Cancer Prosensa (RNA) ARGOS (ARGS) SYNTA (SNTA) Biogen Idec (BIIB) C4 Therapeutics Auspex (ASPX) Dendreon (DNDN) Sarepta (SRPT) ACADIA (ACAD) OSI (OSIP)